"Singing River Health System’s Regional Cancer Center provides a full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care."

During the past decade, Regional Cancer Center at Singing River Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 47 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Cancer Center at Singing River Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 23 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Cancer Center at Singing River Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Regional Cancer Center at Singing River Hospital" are "Lung Cancer" (18 trials), "Breast Cancer" (15 trials), "Prostate Cancer" (8 trials), "Colorectal Cancer" (5 trials) and "Head and Neck Cancer" (5 trials). Many other conditions were trialed in "Regional Cancer Center at Singing River Hospital" in a lesser frequency.

Most popular intervention types in "Regional Cancer Center at Singing River Hospital" are "Drug" (51 trials), "Radiation" (27 trials), "Other" (15 trials), "Biological" (12 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "cisplatin" (8 trials), "docetaxel" (7 trials), "placebo" (7 trials) and "cetuximab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Regional Cancer Center at Singing River Hospital" are 42 trials for "All" genders, 15 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Regional Cancer Center at Singing River Hospital". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Regional Cancer Center at Singing River Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Cancer Center at Singing River Hospital, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".